Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
Top Cited Papers
- 1 December 2009
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 8 (12), 1150-1157
- https://doi.org/10.1016/s1474-4422(09)70238-8
Abstract
No abstract availableKeywords
Funding Information
- The Movement Disorder Society and the National Institutes of Health (R13 NS062643-01)
This publication has 89 references indexed in Scilit:
- Familial parkinsonism: Study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomesParkinsonism & Related Disorders, 2009
- Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunctionActa Neuropathologica, 2009
- Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra NeuronsNeuron, 2009
- DCTN1 mutations in Perry syndromeNature Genetics, 2009
- Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendationsActa Neuropathologica, 2008
- Evaluation of α-synuclein immunohistochemical methods used by invited expertsActa Neuropathologica, 2008
- Morphometry of the human substantia nigra in ageing and Parkinson’s diseaseActa Neuropathologica, 2008
- Applicability of current staging/categorization of α-synuclein pathology and their clinical relevanceActa Neuropathologica, 2008
- Cell systems and the toxic mechanism(s) of α-synucleinExperimental Neurology, 2008
- Reduced striatal tyrosine hydroxylase in incidental Lewy body diseaseActa Neuropathologica, 2007